Driehaus Capital Management LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 938206 Chicago, IL

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$230,963,605

+$69,289,869 QoQ

Shares Held

1,740,101

-9.4% QoQ

Ownership

2.30%

of shares outstanding

% of Portfolio

1.34%

of 13F equity value

Holder Rank

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 83% Shared 0% None 17%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. APGE ranks #6 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc.	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc. This page	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc.	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$230,963,605	1,740,101	-9.4%	Shares	Sole	2026-08-14
2026-03-31	$161,673,736	1,920,800	-12.0%	Shares	Sole	2026-05-15
2025-12-31	$164,825,977	2,183,704	+1.2%	Shares	Sole	2026-02-17
2025-09-30	$85,757,284	2,158,502	-6.6%	Shares	Sole	2025-11-14
2025-06-30	$100,356,089	2,310,755	-1.2%	Shares	Sole	2025-08-14
2025-03-31	$87,406,073	2,339,563	-10.2%	Shares	Sole	2025-05-15
2024-12-31	$118,020,543	2,605,310	+2.8%	Shares	Sole	2025-02-14
2024-09-30	$148,824,075	2,533,607	+19.6%	Shares	Sole	2024-11-14
2024-06-30	$83,338,184	2,117,870	+2.6%	Shares	Sole	2024-08-15
2024-03-31	$137,137,051	2,063,763	+55.3%	Shares	Sole	2024-05-15
2023-12-31	$37,134,048	1,329,064	-0.8%	Shares	Sole	2024-02-14
2023-09-30	$28,526,557	1,339,275	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.